CVE-2026-5707Command Injection via Virtual Desktop Session Name in AWS Research and Engineering Studio (RES)
Updated under an hour ago ()
Does this affect you?
It affects AWS Research and Engineering Studio (RES) and 1 other product. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Unsanitized input in an OS command in the virtual desktop session name handling in AWS Research and Engineering Studio (RES) version 2025.03 through 2025.12.01 might allow a remote authenticated actor to execute arbitrary commands as root on the virtual desktop host via a crafted session name. To remediate this issue, users are advised to upgrade to RES version 2026.03 or apply the corresponding mitigation patch to their existing environment.
- CVSS
- 8.8 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-78
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- AMZN
- NVD analysis
- Analyzed
- Record last updated
- Apr 7, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
AWS Research and Engineering Studio (RES) aws:research_and_engineering_studio_res (from the name) | from 2025.03 through 2025.12.01 | CNA record |
amazon research_and_engineering_studio amazon:research_and_engineering_studio | before 2026.03 | NVD |
References
- https://github.com/aws/res/releases/tag/2026.03release-notes
- https://github.com/aws/res/issues/151patch, exploit, issue-tracking
- https://aws.amazon.com/security/security-bulletins/2026-014-aws/vendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.